The impact of inflammatory bowel diseases on the development of atherosclerosis and cardiovascular risk

Objective: To study the impact of inflammatory bowel diseases (IBD) on the development of atherosclerosis and assess cardiovascular risk in patients without established cardiovascular pathology. Materials and Methods. The study included 115 patients divided into three groups: 37 patients with Crohn’...

Full description

Saved in:
Bibliographic Details
Main Authors: G. O. Isaev, O. Iu. Trushina, M. A. Isaikina, A. A. Bestavashvili, E. S. Zadykyan, M. V. Yurazh, Ph. Yu. Kopylov, M. H. Mnatsakanyan, V. V. Fomin
Format: Article
Language:Russian
Published: InterMedservice 2025-06-01
Series:Евразийский Кардиологический Журнал
Subjects:
Online Access:https://www.heartj.asia/jour/article/view/6519
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849244969939763200
author G. O. Isaev
O. Iu. Trushina
M. A. Isaikina
A. A. Bestavashvili
E. S. Zadykyan
M. V. Yurazh
Ph. Yu. Kopylov
M. H. Mnatsakanyan
V. V. Fomin
author_facet G. O. Isaev
O. Iu. Trushina
M. A. Isaikina
A. A. Bestavashvili
E. S. Zadykyan
M. V. Yurazh
Ph. Yu. Kopylov
M. H. Mnatsakanyan
V. V. Fomin
author_sort G. O. Isaev
collection DOAJ
description Objective: To study the impact of inflammatory bowel diseases (IBD) on the development of atherosclerosis and assess cardiovascular risk in patients without established cardiovascular pathology. Materials and Methods. The study included 115 patients divided into three groups: 37 patients with Crohn’s disease (CD), 44 patients with ulcerative colitis (UC), and 34 patients in a control group without signs of IBD or other risk factors. All participants underwent carotid artery ultrasound (CAU), assessment of 10-year cardiovascular risk using the Framingham scale, and evaluation of basic laboratory parameters. Results. Patients with IBD demonstrated an increased intima-media thickness (IMT) of the common carotid artery (CCA): in the UC group, the IMT on the right side was 0.08 cm, and on the left side was 0.07 cm (p=0.019 and p=0.012, respectively); in the CD group, the IMT was 0.07 cm (p=0.001). In the control group, the IMT was 0.06 cm. Levels of C-reactive protein (CRP) and fibrinogen were significantly higher in the IBD groups compared to controls. The calculation of 10-year cardiovascular risk using the Framingham scale revealed no significant differences between the groups: the median risk was 1.54% [0.99-2.68] for the CD group, 1.59% [1.25-2.7] for the UC group, and 1.32% [1.04-2.17] for the control group (p=0.625). The number of patients with moderate and high risk (>10%) also did not differ significantly between the groups (p=0.135). Conclusion: IBD is associated with thickening of vascular walls and elevated levels of inflammatory markers, which may indicate an increased risk of developing atherosclerosis. However, the cardiovascular risk calculated using the Framingham scale did not differ significantly between the groups, highlighting the potential need for additional risk assessment in patients with IBD.
format Article
id doaj-art-281e3dd8795d4c82a188bcd3a9ce9e73
institution Kabale University
issn 2225-1685
2305-0748
language Russian
publishDate 2025-06-01
publisher InterMedservice
record_format Article
series Евразийский Кардиологический Журнал
spelling doaj-art-281e3dd8795d4c82a188bcd3a9ce9e732025-08-20T03:58:59ZrusInterMedserviceЕвразийский Кардиологический Журнал2225-16852305-07482025-06-0102586410.38109/2225-1685-2025-2-58-646381The impact of inflammatory bowel diseases on the development of atherosclerosis and cardiovascular riskG. O. Isaev0O. Iu. Trushina1M. A. Isaikina2A. A. Bestavashvili3E. S. Zadykyan4M. V. Yurazh5Ph. Yu. Kopylov6M. H. Mnatsakanyan7V. V. Fomin8I.M. Sechenov first Moscow state medical university (Sechenov University)I.M. Sechenov first Moscow state medical university (Sechenov University)I.M. Sechenov first Moscow state medical university (Sechenov University)I.M. Sechenov first Moscow state medical university (Sechenov University)I.M. Sechenov first Moscow state medical university (Sechenov University)I.M. Sechenov first Moscow state medical university (Sechenov University)I.M. Sechenov first Moscow state medical university (Sechenov University)I.M. Sechenov first Moscow state medical university (Sechenov University)I.M. Sechenov first Moscow state medical university (Sechenov University)Objective: To study the impact of inflammatory bowel diseases (IBD) on the development of atherosclerosis and assess cardiovascular risk in patients without established cardiovascular pathology. Materials and Methods. The study included 115 patients divided into three groups: 37 patients with Crohn’s disease (CD), 44 patients with ulcerative colitis (UC), and 34 patients in a control group without signs of IBD or other risk factors. All participants underwent carotid artery ultrasound (CAU), assessment of 10-year cardiovascular risk using the Framingham scale, and evaluation of basic laboratory parameters. Results. Patients with IBD demonstrated an increased intima-media thickness (IMT) of the common carotid artery (CCA): in the UC group, the IMT on the right side was 0.08 cm, and on the left side was 0.07 cm (p=0.019 and p=0.012, respectively); in the CD group, the IMT was 0.07 cm (p=0.001). In the control group, the IMT was 0.06 cm. Levels of C-reactive protein (CRP) and fibrinogen were significantly higher in the IBD groups compared to controls. The calculation of 10-year cardiovascular risk using the Framingham scale revealed no significant differences between the groups: the median risk was 1.54% [0.99-2.68] for the CD group, 1.59% [1.25-2.7] for the UC group, and 1.32% [1.04-2.17] for the control group (p=0.625). The number of patients with moderate and high risk (>10%) also did not differ significantly between the groups (p=0.135). Conclusion: IBD is associated with thickening of vascular walls and elevated levels of inflammatory markers, which may indicate an increased risk of developing atherosclerosis. However, the cardiovascular risk calculated using the Framingham scale did not differ significantly between the groups, highlighting the potential need for additional risk assessment in patients with IBD.https://www.heartj.asia/jour/article/view/6519inflammatory bowel diseasesatherosclerosiscardiovascular riskframingham scalecarotid artery ultrasoundc-reactive proteinfibrinogenintima-media thicknessinflammationprognosis
spellingShingle G. O. Isaev
O. Iu. Trushina
M. A. Isaikina
A. A. Bestavashvili
E. S. Zadykyan
M. V. Yurazh
Ph. Yu. Kopylov
M. H. Mnatsakanyan
V. V. Fomin
The impact of inflammatory bowel diseases on the development of atherosclerosis and cardiovascular risk
Евразийский Кардиологический Журнал
inflammatory bowel diseases
atherosclerosis
cardiovascular risk
framingham scale
carotid artery ultrasound
c-reactive protein
fibrinogen
intima-media thickness
inflammation
prognosis
title The impact of inflammatory bowel diseases on the development of atherosclerosis and cardiovascular risk
title_full The impact of inflammatory bowel diseases on the development of atherosclerosis and cardiovascular risk
title_fullStr The impact of inflammatory bowel diseases on the development of atherosclerosis and cardiovascular risk
title_full_unstemmed The impact of inflammatory bowel diseases on the development of atherosclerosis and cardiovascular risk
title_short The impact of inflammatory bowel diseases on the development of atherosclerosis and cardiovascular risk
title_sort impact of inflammatory bowel diseases on the development of atherosclerosis and cardiovascular risk
topic inflammatory bowel diseases
atherosclerosis
cardiovascular risk
framingham scale
carotid artery ultrasound
c-reactive protein
fibrinogen
intima-media thickness
inflammation
prognosis
url https://www.heartj.asia/jour/article/view/6519
work_keys_str_mv AT goisaev theimpactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk
AT oiutrushina theimpactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk
AT maisaikina theimpactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk
AT aabestavashvili theimpactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk
AT eszadykyan theimpactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk
AT mvyurazh theimpactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk
AT phyukopylov theimpactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk
AT mhmnatsakanyan theimpactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk
AT vvfomin theimpactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk
AT goisaev impactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk
AT oiutrushina impactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk
AT maisaikina impactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk
AT aabestavashvili impactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk
AT eszadykyan impactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk
AT mvyurazh impactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk
AT phyukopylov impactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk
AT mhmnatsakanyan impactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk
AT vvfomin impactofinflammatoryboweldiseasesonthedevelopmentofatherosclerosisandcardiovascularrisk